English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

Study identifies genetic causes of inherited bone marrow failure and cancer risk
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

PIWI proteins and piRNAs may improve future stem cell therapies, review says
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

Sanofi suspends Phase 2 lung study as CEO reviews drug pipeline
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

New analysis highlights Megalin's role in disease management and cellular health
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Study links persistent media skepticism to common vaccine conspiracy beliefs in Japan
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Researchers develop organoid biobank to map cancer gene dependencies
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

American Lung Association expands clean air initiative in the Bronx amid rising pollution concerns
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Cellular senescence identified as key factor in spinal disc degeneration and pain

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'